Neurotech International Limited (ASX:NTI)
Australia · Delayed Price · Currency is AUD 0.0130
-0.0020 (-13.33%)
Jan 30, 2026, 4:10 PM AEST
Neurotech International Market Cap
Neurotech International has a market cap or net worth of 19.44 million as of January 29, 2026. Its market cap has decreased by -65.45% in one year.
Market Cap
19.44M
Enterprise Value
16.41M
Revenue
2.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since November 4, 2016, Neurotech International's market cap has decreased from 25.09M to 19.44M, a decrease of -22.50%. That is a compound annual growth rate of -2.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 19.44M | 7.14% |
| Dec 31, 2025 | 18.15M | -68.34% |
| Dec 31, 2024 | 57.32M | -6.85% |
| Dec 29, 2023 | 61.53M | 8.18% |
| Dec 29, 2022 | 56.88M | 35.96% |
| Dec 31, 2021 | 41.83M | 65.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Algorae Pharmaceuticals | 35.46M |
| Avecho Biotechnology | 33.06M |
| Argenica Therapeutics | 32.76M |
| Noxopharm | 23.38M |
| Tissue Repair | 18.44M |
| Immuron | 12.69M |
| AdAlta | 11.48M |
| Chimeric Therapeutics | 11.05M |